44 pending office actions • 27 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19245022 | COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF INHIBIN SUBUNIT BETA E (INHBE) GENES | BASECURE THERAPEUTICS LLC | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Non-Final OA | Jun 20, 2025 |
| 19245028 | COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF INHIBIN SUBUNIT BETA E (INHBE) GENES | BASECURE THERAPEUTICS LLC | VANHORN, ABIGAIL LOUISE | 1636 | Final Rejection | Jun 20, 2025 |
| 18621534 | ANTI-TREM-1 ANTIBODIES AND USES THEREOF | Bristol-Myers Squibb Company | LOCKARD, JON MCCLELLAND | 1647 | Non-Final OA | Mar 29, 2024 |
| 18580559 | LPA1 SMALL MOLECULE ANTAGONIST | Tuojie Biotech (Shanghai) Co., Ltd. | YOO, SUN JAE | 1621 | Non-Final OA | Jan 18, 2024 |
| 18564512 | QUINOLINAMINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PHARMACEUTICALS | Shanghai Hengrui Pharmaceutical Co., Ltd. | LAU, JONATHAN S | 1693 | Non-Final OA | Nov 27, 2023 |
| 18564584 | RECOMBINANT ADENO-ASSOCIATED VIRUS HAVING VARIANT CAPSID, AND APPLICATION THEREOF | Shanghai Regenelead Therapies Co., Ltd. | ROGERS, ERIC JASON | 1638 | Non-Final OA | Nov 27, 2023 |
| 18562459 | METHODS FOR INDUCING VASODILATION | The University of Melbourne | BOATENG, AFUA BAMFOAA | 1617 | Non-Final OA | Nov 20, 2023 |
| 18288970 | POLYMER AND COMPOSITION THEREOF | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ALLEY, GENEVIEVE S | 1617 | Non-Final OA | Oct 30, 2023 |
| 18287756 | SIRNA TARGETING 17Beta-HYDROXYSTEROID DEHYDROGENASE TYPE 13 AND SIRNA CONJUGATE | Tuojie Biotech(Shanghai) Co., Ltd. | MEYERING, SHABANA SHABBEER | 1635 | Non-Final OA | Oct 20, 2023 |
| 18489420 | PRODUCTION OF TRICHODERMA SPP FUNGI USING ALMOND HULL AS A GROWTH MEDIUM | Select Harvests Limited | WILLIAMS, EMMALEE RAE | 1653 | Non-Final OA | Oct 18, 2023 |
| 18555385 | SIGNAL PEPTIDES | Imperial College Innovations Limited | POPA, ILEANA | 1633 | Non-Final OA | Oct 13, 2023 |
| 18286536 | BORIC ACID DERIVATIVE ACTING AS Beta-LACTAMASE INHIBITOR | Tuojie Biotech (Shanghai) Co., Ltd. | SHIAO, REI TSANG | 1691 | Non-Final OA | Oct 11, 2023 |
| 18284009 | TRUNCATED TACI POLYPEPTIDE AND FUSION PROTEIN AND USE THEREOF | Shanghai Hengrui Pharmaceutical Co., Ltd. | BRISTOL, LYNN ANNE | 1643 | Non-Final OA | Sep 25, 2023 |
| 18456354 | RETROVIRAL VECTORS | Ip2Ipo Innovations Limited | ALAM, DANYAL HASSAN | 1672 | Non-Final OA | Aug 25, 2023 |
| 18278373 | ANTIBODIES AGAINST CLAUDIN-6 AND USES THEREOF | Novarock Biotherapeutics, Ltd. | DIBRINO, MARIANNE | 1641 | Non-Final OA | Aug 22, 2023 |
| 18272336 | A PROCESS FOR RECOVERING COBALT FROM LITHIUM-ION BATTERIES | Newsouth Innovations Pty Ltd | PARK, LISA S | 1729 | Non-Final OA | Jul 13, 2023 |
| 18255823 | PERI-ORBITAL FULLNESS ASSESSMENT SCALE AND METHODS OF USE THEREOF | Standard Of Care Corporation | LIEB, JEANETTE M | 1654 | Non-Final OA | Jun 02, 2023 |
| 18036587 | PHARMACEUTICAL COMPOSITION COMPRISING HUMAN INTERLEUKIN 2 VARIANT OR DERIVATIVE THEREOF AND USE THEREOF | Shanghai Shengdi Pharmaceutical Co., Ltd. | DONOGHUE, BRITTNEY ERIN | 1675 | Non-Final OA | May 11, 2023 |
| 18032086 | ANTI-HER3 ANTIBODY AND ANTI-HER3 ANTIBODY-DRUG CONJUGATE AND MEDICAL USE THEREOF | Shanghai Hengrui Pharmaceutical Co., Ltd. | STONEBRAKER, ALYSSA RAE | 1642 | Non-Final OA | Apr 14, 2023 |
| 18298882 | COMBINATION TREATMENT | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | SHIBUYA, MARK LANCE | 1631 | Non-Final OA | Apr 11, 2023 |
| 18024631 | DERIVATISATION OF PEPTIDES AND PROTEINS | Florey Institute Of Neuroscience And Mental Health | CHANDRA, GYAN | 1674 | Non-Final OA | Mar 03, 2023 |
| 18024725 | A PROCESS FOR PREPARING FERTILIZER COMPOSITIONS | Select Harvests Limited | SILVA RAINBOW, HEATHER ELISE | 1731 | Non-Final OA | Mar 03, 2023 |
| 18023359 | DRUG-LOADED MACROMOLECULE AND PREPARATION METHOD THEREFOR | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | BRANDSEN, BENJAMIN MICHAEL | 1693 | Non-Final OA | Feb 25, 2023 |
| 18023301 | SIGNAL PEPTIDE FOR REDUCING END HETEROGENEITY OF HETEROLOGOUS POLYPEPTIDE | Shanghai Hengrui Pharmaceutical Co., Ltd. | GANGLE, BRIAN J | 1645 | Non-Final OA | Feb 24, 2023 |
| 18022091 | HYALURONIDASE FUSION PROTEINS COMPRISING A TARGETING SEQUENCE AND METHODS OF USING SAME TO TREAT A COSMETIC CONDITION | Standard Of Care Corporation | CURRENS, GRANT CARSON | 1651 | Final Rejection | Feb 17, 2023 |
| 18020055 | BENZIMIDAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | Tuojie Biotech(Shanghai) Co., Ltd. | CHICKS, ASHLI ARIANA | 1626 | Non-Final OA | Feb 06, 2023 |
| 18019465 | USE OF BTK INHIBITORS IN THE TREATMENT OF DISEASES | Reistone Biopharma Company Limited | RODRIGUEZ, RAYNA B | 1628 | Non-Final OA | Feb 02, 2023 |
| 18018471 | ANTI-PD-1 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF | Shanghai Hengrui Pharmaceutical Co., Ltd. | SWARTWOUT, BRIANNA KENDALL | 1644 | Non-Final OA | Jan 27, 2023 |
| 18017388 | SULFUR-CONTAINING ISOINDOLINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | Shanghai Hengrui Pharmaceutical Co., Ltd. | RZECZYCKI, PHILLIP MATTHEW | 1625 | Final Rejection | Jan 20, 2023 |
| 18014053 | IMMUNE PROFILING AND METHODS OF USING SAME TO PREDICT RESPONSIVENESS TO AN IMMUNOTHERAPY AND TREAT CANCER | Gopath Laboratories LLC | SITTON, JEHANNE SOUAYA | 1682 | Non-Final OA | Dec 30, 2022 |
| 18013524 | ANTI-FXI/FXIA ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND PHARMACEUTICAL USE THEREOF | BEIJING TUO JIE BIOPHARMACEUTICAL CO. LTD. | ALLEN, MARIANNE P | 1647 | Non-Final OA | Dec 28, 2022 |
| 18013231 | ANTI-CD70 ANTIBODY AND APPLICATION THEREOF | Shanghai Hengrui Pharmaceutical Co., Ltd. | WEIDNER, ADAM M | 1675 | Non-Final OA | Dec 27, 2022 |
| 17995700 | TREATMENT FOR SEPSIS-INDUCED ORGAN DYSFUNCTION | Rinaldo Bellomo | VALLE, ERNESTO | 1623 | Non-Final OA | Oct 06, 2022 |
| 17914087 | PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODY DRUG CONJUGATE AND USE THEREOF | Shanghai Hengrui Pharmaceutical Co., Ltd. | KIM, YUNSOO | 1641 | Final Rejection | Sep 23, 2022 |
| 17910292 | METHODS AND MATERIALS FOR DISSEMINATING A PROTEIN THROUGHOUT THE CENTRAL NERVOUS SYSTEM | Remotor Therapeutics, Inc. | SPENCER, ANDREA LYNNE MORRIS | 1631 | Non-Final OA | Sep 08, 2022 |
| 17794732 | DRUG CONJUGATE OF ERIBULIN DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE | Jiangsu Hengrui Medicine Co., Ltd. | SKOKO III, JOHN JOSEPH | 1643 | Final Rejection | Jul 22, 2022 |
| 17794213 | ANTI-ANGPTL3 ANTIBODY AND USE THEREOF | Shanghai Hengrui Pharmaceutical Co., Ltd. | SAOUD, CHRISTINE J | 1645 | Non-Final OA | Jul 20, 2022 |
| 17793005 | ANTI-TROP-2 ANTIBODY-EXATECAN ANALOG CONJUGATE AND MEDICAL USE THEREOF | Shanghai Hengrui Pharmaceutical Co., Ltd. | PUTTLITZ, KARL J | 1646 | Non-Final OA | Jul 14, 2022 |
| 17627085 | ANTIBODIES AGAINST HUMAN TREM-1 AND USES THEREOF | Bristol-Myers Squibb Company | SHUPE, ELIZABETH A | 1643 | Non-Final OA | Jan 13, 2022 |
| 17610440 | ANTIFUNGAL AGENTS FOR CANDIDA AURIS DECOLONIZATION | Scynexis, Inc. | GALSTER, SAMUEL LEONARD | 1693 | Non-Final OA | Nov 10, 2021 |
| 17436044 | INTRAGENIC ASSESSMENT AND METHODS THEREFOR | The Sydney Children's Hospitals Network | LAFAVE, ELIZABETH ROSE | 1684 | Final Rejection | Sep 02, 2021 |
| 17399015 | ANTIFUNGAL AGENTS USED IN COMBINATION | Scynexis, Inc. | LEE, WILLIAM Y | 1623 | Non-Final OA | Aug 10, 2021 |
| 17202453 | NOVEL HEALTHCARE DELIVERY, TREATMENT, AND PAYMENT MODEL FOR SPECIALTY DRUGS | Klaritos, Inc. | ALDERSON, ANNE-MARIE K | 3682 | Final Rejection | Mar 16, 2021 |
| 16971500 | METHODS OF PERFORMING CLINICAL TRIALS | Klaritos, Inc. | ERICKSON, BENNETT S | 3683 | Final Rejection | Aug 20, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial